Dechra Pharmaceuticals PLC

(the 'Company')

30 September 2009

In conformity with DTR 5.6.1R, the Company notifies the market of the following:

As at the date of this announcement, the Company's issued share capital consists of 65,588,924 ordinary shares with a nominal value of 1 pence each ('Ordinary Shares'), with voting rights. The Company does not hold any Ordinary Shares in Treasury.

Therefore, the total number of Ordinary Shares with voting rights is 65,588,924.

The above figure of 65,588,924 Ordinary Shares may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FSA's Disclosure and Transparency Rules.

For further information

Zoe Goulding, Company Secretary        

Telephone number: 01782 771100